Porous Elastomer Coating for Implantable Devices
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Implantable medical devices often induce a foreign body response leading to fibrous capsule formation and capsular contracture, which can cause aesthetic and painful issues, and existing textured surfaces do not fully prevent these complications.
Innovation Solution
A porous material with a substantially non-degradable, biocompatible elastomer matrix featuring an array of interconnected pores is developed, which promotes cellular ingrowth and reduces fibrous capsule formation by anchoring to surrounding tissue, thereby preventing capsular contracture and scarring.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If a smooth surface is used on implantable medical devices, then manufacturing is simple, but foreign body response and fibrous capsule formation occur
Solution Approach 1:
The patent applies porous materials by creating a porous coating layer on the implantable medical device surface. This porous structure allows tissue ingrowth into the device, promoting integration with surrounding tissue and reducing foreign body response. The pores provide pathways for cellular infiltration and tissue anchoring, effectively preventing fibrous capsule formation while maintaining manufacturing feasibility through coating processes.
Solution Approach 2:
The patent employs composite materials by combining the device base material with a porous coating layer. This composite structure integrates the benefits of the base material with the tissue-friendly properties of the porous coating, creating a multi-layered surface that reduces capsular contracture while maintaining device functionality and manufacturability.
2Object-affected harmful factors
If a textured surface is imprinted on implantable medical devices, then capsular formation is reduced, but capsular contracture can still occur and manufacturing complexity increases
Solution Approach 1:
The patent transitions from surface texturing to a porous volume structure. Instead of merely imprinting hills and valleys on the surface, the invention creates a three-dimensional porous network that extends into the coating layer. This porous architecture provides deeper tissue ingrowth pathways and more effective prevention of capsular contracture compared to surface texturing alone.
Solution Approach 2:
The patent applies dimensionality change by moving from two-dimensional surface texturing to three-dimensional porous structure. The porous coating layer extends the anti-capsular effect into the depth dimension, creating interconnected voids that allow tissue penetration and anchoring, thereby enhancing the effectiveness against capsular contracture.
3Object-affected harmful factors
If porous materials are used to promote cellular ingrowth, then fibrous capsule formation is reduced, but manufacturing process complexity increases
Solution Approach 1:
The patent applies preliminary action by pre-forming porous structures (such as foam or scaffold materials) before applying them to the device surface. These pre-formed porous components are then integrated into the device coating system, allowing the porous structure to be established before final device assembly. This approach simplifies the overall manufacturing process compared to creating porous structures in-situ during device fabrication.
Data Source
AI summary
The present specification discloses porous materials, methods of forming such porous materials, biocompatible implantable devices comprising such porous materials, and methods of making such biocompatible implantable devices.